Gilead Sciences and Boehringer Ingelheim GmbH are halting price increases on their AIDS drugs for selected U.S. and state government agencies, the AIDS Healthcare Foundation said Tuesday. The advocacy group said it requested the suspension to help government programs address problems in expanding access to lifesaving AIDS treatments. Gilead manufactures Viread, Truvada and Emtriva, while Boehringer makes Aptivus.

Full Story:

Related Summaries